What is Lucid Diagnostics's debt-to-equity?

Lucid Diagnostics (LUCD) reported debt-to-equity of 0.4× in Q1 2026.

What is the long-term trend for Lucid Diagnostics's debt-to-equity?

Over 2 years (2022 to 2025), Lucid Diagnostics's debt-to-equity has grown at a 38.5% compound annual growth rate (CAGR), from 0.1× to 0.2×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Lucid Diagnostics LUCD Debt-to-equity

Debt-to-equity at other companies

Castle BiosciencesCSTL

0.1×0.0×

Guardant HealthGH

3×—

Biodesix, Inc.BDSX

7.8×+2.2×

Insight Molecular Diagnostics Inc. Common StockIMDX

2.9×+2.8×

Fulgent Genetics, Inc.FLGT

0×0.0×

Personalis, Inc.PSNL

0.2×0.0×

Other financials

Income statement

See full

Revenue$1.3M+51.7%

Gross profit-$369.0K+49.0%

Operating income-$12.1M+3.0%

Net income-$13.9M+48.3%

EPS (diluted)-$0.10+60.0%

Balance sheet

See full

Cash & equivalents$27.9M+10.6%

Total debt$1.6M-35.1%

Total equity$4.0M+174%

Total assets$34.1M+3.9%

Cash flow

See full

Operating cash flow-$12.1M+2.9%

CapEx$215.0K+131%

Free cash flow-$12.3M+1.9%

Valuation

See full

Market cap$204.13M+58.5%

Enterprise value$177.85M+78.0%

P/S39.8×+10.2×

Profitability

See full

Gross margin-66.8%—

Operating margin-959.6%-133pp

Net margin-876.7%-254pp

FCF margin-1,099.6%—

Returns & leverage

See full

Return on equity-710.6%—

Current ratio1.1×+0.3×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

total debt/total stockholders equity=0.4×

Based on the most recent quarter.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lucid Diagnostics's debt-to-equity?: Lucid Diagnostics (LUCD) reported debt-to-equity of 0.4× in Q1 2026.
What is the long-term trend for Lucid Diagnostics's debt-to-equity?: Over 2 years (2022 to 2025), Lucid Diagnostics's debt-to-equity has grown at a 38.5% compound annual growth rate (CAGR), from 0.1× to 0.2×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.